Stock Alert: Nurix Therapeutics Gains 8%

By RTTNews Staff Writer   ✉   | Published:

Shares of Nurix Therapeutics Inc. (NRIX) are gaining over 8% on Friday morning. The biopharmaceutical company announced pricing of upsized public offering, raising $139.5 million.

NRIX is currently trading at $35.35, up $2.86 or 8.80%, on the Nasdaq.

Nurix Therapeutics priced its offering of 4.5 million common shares at $31.00 per share. The offering was upsized from the previously announced size of 4 million shares.

The proceeds are expected to be $139.5 million. The offering is expected to close on March 9, 2021.

For comments and feedback contact: editorial@rttnews.com

Business News

Next Story
Editors Pick
Polaris Recalls Ranger Off-Road Vehicles, PRO XD Utility Vehicles
Polaris Industries Inc. recalled about 15,800 units of Off-Road and Utility Vehicles in North America for possible crash hazard, according to a statement issued by the U.S. Consumer Product Safety Commission. There were also an additional 711 units sold in Canada.
EU, Italy Block AstraZeneca COVID-19 Vaccine Shipment To Australia
AstraZeneca's efforts to supply Covid-19 vaccine doses from its Italian unit to Australia has been blocked by the European Union and the Italian Government, citing Australia being non-vulnerable region and delays in domestic supply, among others. Italy's proposal to deny AstraZeneca's request for authorization to export COVID-19 vaccines was subsequently approved by the European Commission.
Chipotle In Deal With E.l.f. For Vegan, Cruelty-free Makeup Collection
Chipotle Mexican Grill, Inc. is teaming with e.l.f. Cosmetics to launch a limited edition beauty collection on March 10, aiming to support plant-based lifestyles and responsibly-sourced products. The e.l.f. x Chipotle makeup collection will comprise cruelty-free and vegan products inspired by Chipotle's responsibly-raised food.